Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Orton

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2025
Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidaseNicola Colclough, Alexandra L Orton, Scott Martin, et al.
Bioorganic & Medicinal Chemistry|October 22, 2020
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitorsSébastien L Degorce, Anna Aagaard, Rana Anjum, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Scientific Reports|February 25, 2022
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facilityJulie A Douthwaite, Christopher A Brown, John R Ferdinand, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2025
Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidaseNicola Colclough, Alexandra L Orton, Scott Martin, et al.
Bioorganic & Medicinal Chemistry|October 22, 2020
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitorsSébastien L Degorce, Anna Aagaard, Rana Anjum, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Scientific Reports|February 25, 2022
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facilityJulie A Douthwaite, Christopher A Brown, John R Ferdinand, et al.
Pageof 5